bexarotene has been researched along with mechlorethamine in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Duvic, M | 1 |
| Bradley, B; Parker, SR | 1 |
| Acebo, E; Díaz-Pérez, JL; García-Ruiz, JC; Izu, R; Martínez de Lagrán, Z; Pérez-Barrio, S | 1 |
| Cutlan, J; Duvic, M; Holcomb, M | 1 |
| Chen, PL; Malachowski, SJ; Seminario-Vidal, L; Sun, J | 1 |
| Assaf, C; Querfeld, C; Scandurra, M; Scarisbrick, JJ; Turini, M | 1 |
4 review(s) available for bexarotene and mechlorethamine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Current treatment of Cutaneous T-Cell Lymphoma.
Topics: Administration, Oral; Administration, Topical; Anticarcinogenic Agents; Apoptosis; Bexarotene; Biopsy; Carmustine; Disease Progression; Drug Eruptions; Humans; Hypertriglyceridemia; Lymphoma, T-Cell, Cutaneous; Mechlorethamine; Neoplasm Staging; Prognosis; PUVA Therapy; Retinoids; Sezary Syndrome; Tetrahydronaphthalenes; Vitamin D | 2001 |
Treatment of cutaneous T-cell lymphoma/mycosis fungoides.
Topics: Administration, Cutaneous; Anti-Inflammatory Agents; Antineoplastic Agents; Bexarotene; Biopsy; Cost of Illness; Diphtheria Toxin; Foundations; Humans; Hydroxamic Acids; Interferons; Interleukin-2; Mechlorethamine; Mycosis Fungoides; Neoplasm Staging; Photopheresis; Phototherapy; Physical Examination; Radiotherapy; Recombinant Fusion Proteins; Retinoids; Self-Help Groups; Skin Care; Skin Neoplasms; Tetrahydronaphthalenes; Vorinostat | 2006 |
Diagnosis and Management of Cutaneous B-Cell Lymphomas.
Topics: Administration, Cutaneous; Adrenal Cortex Hormones; Anti-Bacterial Agents; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bexarotene; Borrelia burgdorferi; Cyclophosphamide; Cytoreduction Surgical Procedures; Dermatologic Surgical Procedures; Disease Management; Doxorubicin; Humans; Injections, Intralesional; Lyme Disease; Lymphoma, B-Cell; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Large B-Cell, Diffuse; Mechlorethamine; Polyethylene Glycols; Prednisone; Rituximab; Skin Neoplasms; Vincristine | 2019 |
1 trial(s) available for bexarotene and mechlorethamine
| Article | Year |
|---|---|
Prior Bexarotene or Phototherapy Does Not Affect Response to Chlormethine Gel: Post Hoc Analysis of a Pivotal Trial.
Topics: Bexarotene; Humans; Mechlorethamine; Phototherapy; Skin Neoplasms | 2023 |
2 other study(ies) available for bexarotene and mechlorethamine
| Article | Year |
|---|---|
[Autologous hematopoietic stem cell transplantation followed by oral bexarotene in a patient with advanced mycosis fungoides].
Topics: Adolescent; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bexarotene; Busulfan; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Humans; Interferon alpha-2; Interferon-alpha; Mechlorethamine; Methylprednisolone; Mycosis Fungoides; Peripheral Blood Stem Cell Transplantation; Prednisone; PUVA Therapy; Recombinant Proteins; Remission Induction; Tetrahydronaphthalenes; Transplantation, Autologous; Vincristine | 2008 |
Erythema gyratum repens-like eruptions with large cell transformation in a patient with mycosis fungoides.
Topics: Aged; Antineoplastic Agents; Bexarotene; Combined Modality Therapy; Electrons; Erythema; Humans; Male; Mechlorethamine; Mycosis Fungoides; Skin Neoplasms; Tetrahydronaphthalenes; Treatment Outcome; Triamcinolone | 2012 |